5J6 Stock Overview
Designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
OssDsign AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.70 |
| 52 Week High | SEK 0.91 |
| 52 Week Low | SEK 0.47 |
| Beta | 0.84 |
| 11 Month Change | 30.78% |
| 3 Month Change | 8.01% |
| 1 Year Change | 24.73% |
| 33 Year Change | -9.31% |
| 5 Year Change | n/a |
| Change since IPO | -51.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5J6 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 4.8% | 2.4% | 0.8% |
| 1Y | 24.7% | -5.0% | 9.1% |
Return vs Industry: 5J6 exceeded the German Medical Equipment industry which returned -5% over the past year.
Return vs Market: 5J6 exceeded the German Market which returned 9.1% over the past year.
Price Volatility
| 5J6 volatility | |
|---|---|
| 5J6 Average Weekly Movement | 16.3% |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 5J6's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 5J6's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 25 | Morten Henneveld | www.ossdsign.com |
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. It offers OssDsign Catalyst, a nanosynthetic bone graft used to help stimulate bone growth in spinal fusions. The company was founded in 2011 and is headquartered in Uppsala, Sweden.
OssDsign AB (publ) Fundamentals Summary
| 5J6 fundamental statistics | |
|---|---|
| Market cap | €70.77m |
| Earnings (TTM) | -€7.85m |
| Revenue (TTM) | €11.06m |
6.4x
P/S Ratio-9.0x
P/E RatioIs 5J6 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5J6 income statement (TTM) | |
|---|---|
| Revenue | SEK 127.49m |
| Cost of Revenue | SEK 14.48m |
| Gross Profit | SEK 113.01m |
| Other Expenses | SEK 203.45m |
| Earnings | -SEK 90.44m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 04, 2025
| Earnings per share (EPS) | -0.93 |
| Gross Margin | 88.64% |
| Net Profit Margin | -70.94% |
| Debt/Equity Ratio | 0.2% |
How did 5J6 perform over the long term?
See historical performance and comparison